Notice of Annual General Meeting and Explanatory Memorandum

Friday, April 28, 2017 6:09 AM UTC

SYDNEY, Australia, April 28, 2017 -- Parnell Pharmaceuticals Holdings Ltd (OTC:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Monday 29 May 2017 at 4:00 p.m. (Central Standard Time) and Tuesday 30 May 2017 at 7:00 a.m. (Australian Eastern Standard Time)

NOTICE OF ANNUAL GENERAL MEETING AND EXPLANATORY MEMORANDUM

Notice is given that the Annual General Meeting of shareholders of Parnell Pharmaceuticals Holdings Ltd (Company) will be held on:

Monday 29 May 2017 at 4:00 p.m. (Central Standard Time) and Tuesday 30 May 2017 at 7:00 a.m. (Australian Eastern Standard Time)

Meeting to be held by teleconference (Dial-in details below):

United States		1 800 444 2801
Australia		02 9037 8402
New Zealand		0 800 440 176
Switzerland		0800 564 606
Netherlands		8000 220 915
United Kingdom		0 800 234 6984
Hong Kong		800 903 191

Participant Code: 5687312

For a link to the full Notice of Annual General Meeting and Explanatory Memorandum please click:
http://www.globenewswire.com/NewsRoom/AttachmentNg/9bf785e5-da8b-4b60-a5d2-d71ace68e95e

______________________

26 April 2017

Dear Shareholder,

On behalf of the Board of Directors of Parnell Pharmaceuticals Holdings Limited (ACN 137 904 413) (Company), I invite you to join us at our Annual General Meeting (AGM), which has been scheduled as follows:

Date:		29 May 2017 (CST), 30 May 2017 (AEST)
Time:		4:00 p.m. (CST), 7:00 a.m. (AEST)
Venue:		Held by telephone conference (dial-in details above) or by physical attendance at:
		Unit 4 Century Estate, 476 Gardeners Road, Alexandria, NSW, 2015

Outline of the items of business

At this AGM, we will provide an opportunity for shareholders to consider the following:

the Company’s financial statements and related documents;
ratification of the appointment of the Company auditor; and
re-election of Dr. Alan Bell as a director of the Company.

Details of these items are contained in the enclosed Notice of AM and Explanatory Memorandum.

Voting at the AGM or by proxy

A proxy form accompanies the enclosed Notice of AGM. If you wish to attend the AGM in person, please bring a copy of the proxy form with you. Registration will be available from 3:30 p.m. (CST). If you are unable to attend in person, I encourage you to appoint a proxy to vote on the resolutions contained in the Notice of AGM on your behalf, by completing and returning the enclosed proxy form. Details of how to submit the proxy form are included with the form.

On behalf of all of the Directors, we look forward to hearing from you at the AGM.

Yours sincerely,

Alan Bell
Chairman

For more information, contact:

Parnell Pharmaceuticals Holdings
Robert Joseph, 913-274-2100
[email protected]

Brad McCarthy, 913-274-2100
[email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Notice of Annual General Meeting and Explanatory Memorandum

Editor's Picks

Welcome to EconoTimes